Evidence map›Paper›PMID 37111104›Full record

Trial reportNutrients2023

Preliminary Comparison of Fractional Absorption of Zinc Sulphate, Zinc Gluconate, and Zinc Aspartate after Oral Supple-Mentation in Healthy Human Volunteers.

Francesco Piacenza, Robertina Giacconi, Laura Costarelli, Marco Malavolta

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Persistent ZnAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. ZnScientific reports · 2025
    Article
  5. IntravenousJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  6. Review
  7. Anti-inflammatory effects ofScientific reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Francesco PiacenzaNational Institute of Research and Care of Aging IRCCS INRCA, 60124 Ancona AN, Italy.ORCID 0000-0001-7440-804X
Robertina GiacconiNational Institute of Research and Care of Aging IRCCS INRCA, 60124 Ancona AN, Italy.ORCID 0000-0002-1468-2140
Laura CostarelliNational Institute of Research and Care of Aging IRCCS INRCA, 60124 Ancona AN, Italy.
Marco MalavoltaNational Institute of Research and Care of Aging IRCCS INRCA, 60124 Ancona AN, Italy.ORCID 0000-0002-8442-1763
Istituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

Regione Marche L.R. 37/99 - DGR 1234/05
6 · The paper itself

Abstract

(1) Background: Zinc is generally used as a nutritional supplement for individuals at nutritional risk, such as older adults. This preliminary study investigated the fractional Zn absorption (FZA) after the supplementation on eight healthy volunteers with three different Zn complexes acquired with milk. (2) Methods: The design was a double-blind, three-period crossover trial. The volunteers were randomly divided into three groups. Each individual consumed 200 mL of bovine milk and rotated through a simultaneous administration of a single oral dose of

Indexed as

Aspartic AcidZinc SulfateAgedGluconatesHealthy VolunteersHumansIntestinal AbsorptionZincZinc CompoundsAspartic AcidGluconatesZinczinc aspartateZinc CompoundsZinc Sulfateabsorptiondouble-blind three-period crossover trialstable isotopeszinczinc-aspartatezinc-gluconatezinc sulphate

Identifiers

PMID37111104
PMCPMC10145390
OpenAlexW4365515431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.